Compugen (NASDAQ: CGEN) says all 2025 shareholder meeting items passed

Rhea-AI Filing Summary

Compugen Ltd. reports that it held its 2025 Annual General Meeting of Shareholders on September 16, 2025. According to the company, all proposals presented to shareholders at the meeting were approved by the required majority, meaning each item on the agenda received sufficient support to pass. The notice of meeting, proxy statement and proxy card had previously been filed with the SEC and are incorporated by reference. The company also states that the information in this report is incorporated by reference into its existing shelf registration statement on Form F-3.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number 000-30902

COMPUGEN LTD.

(Translation of registrant’s name into English)

26 Harokmim Street

Holon 5885849, Israel

(Address of Principal Executive Offices) 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒            Form 40-F ☐

Compugen Ltd.

On September 16, 2025, Compugen Ltd. (the “Company”) held its 2025 Annual General Meeting of Shareholders (the “Meeting”). The Company filed the notice of the Meeting, the proxy statement and the proxy card with the Securities and Exchange Commission as Exhibit 99.1 to the Company’s Report on Form 6-K on August 6, 2025 (File No. 000-30902), which is incorporated herein by reference. All proposals brought before the shareholders at the Meeting were approved by the requisite majority vote of the Company’s shareholders.

The information contained in this Report on Form 6-K is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, as amended, File No. 333-270985.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COMPUGEN LTD.
Date: September 17, 2025	By:	/s/ Eran Ben Dor
		Eran Ben Dor General Counsel

FAQ

What did Compugen Ltd. (CGEN) report in its latest Form 6-K?

Compugen Ltd. reported that it held its 2025 Annual General Meeting of Shareholders on September 16, 2025 and that all proposals brought before shareholders were approved by the requisite majority vote.

Were all proposals approved at Compugen Ltd.’s 2025 Annual General Meeting?

Yes. Compugen Ltd. states that all proposals presented at the 2025 Annual General Meeting of Shareholders were approved by the requisite majority of shareholders.

When was Compugen Ltd.’s 2025 Annual General Meeting of Shareholders held?

The 2025 Annual General Meeting of Shareholders of Compugen Ltd. was held on September 16, 2025.

Where can investors find details of the proposals voted on at Compugen Ltd.’s 2025 AGM?

Details of the proposals are included in the notice of meeting, proxy statement and proxy card that Compugen Ltd. filed as Exhibit 99.1 to a prior Form 6-K dated August 6, 2025, which is incorporated by reference.

How does this Form 6-K relate to Compugen Ltd.’s Form F-3 registration statement?

Compugen Ltd. states that the information in this Form 6-K is incorporated by reference into its Registration Statement on Form F-3, as amended, File No. 333-270985.

Who signed the Compugen Ltd. Form 6-K for the September 2025 report?

The report was signed on behalf of Compugen Ltd. by Eran Ben Dor, General Counsel, dated September 17, 2025.